AL-ZADA ALBERTO AGUILAR: Open Payments
NPI 1679914451 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 4 payments from 4 companies in 2025. Trend: 2023 $110 · 2024 $396 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $141 |
| Boston Scientific Corporation | 1 | $126 |
| Corcept Therapeutics | 1 | $117 |
| Medtronic, Inc. | 1 | $69 |
Products named: DUPIXENT, WATCHMAN FLX, Korlym.
Industry payments across NJ — which companies pay providers there.
